Regeneron drug prevents symptomatic Covid-19 by 81% – With insights from The Wall Street Journal
Regeneron ‘says it will ask federal health regulators to clear use among people who haven’t been vaccinated’, reports The Wall Street Journal.
Regeneron ‘says it will ask federal health regulators to clear use among people who haven’t been vaccinated’, reports The Wall Street Journal.
The drug was effective at a higher dose already in use and a lower dose, which the company said it would seek permission to start selling.
Jeremy Howick writes about the results of what he calls “open label” placebos – experiments where patients are actually told they’re being given a sugar coated shell rather than the real thing.